Site Map - Avastin (bevacizumab)

Print Page |
Site Map

Site Map

Avastin Overview
- Proposed Mechanism of Action
  - Proposed Mechanism of Action Summary
    - Role of VEGF
    - Inhibiting Angiogenesis
  - The Multiple Effects of Avastin
    - Anti-vascular Effects
    - Anti-angiogenesis
    - Anti-permeability
    - Continuation Rationale
    - Clinical Trials Design
- About Avastin
  - Dosing and Administration
- Prescribing Information
- Resources
  - Downloads
  - Additional MOA Resources
  - Cancer Links
- Reimbursement
  - Co-Pay Card

Avastin & Colorectal Cancer
- Efficacy in MCRC
  - Efficacy & Safety Overview
  - First-line MCRC
  - Second-line MCRC
- Dose and Duration in MCRC
- MCRC Resources
  - FAQ
  - Proteinuria and Hypertension QH
  - MCRC Downloads
- Safety Information
- Prescribing Information

Avastin & Lung Cancer
- Efficacy and Safety in NSCLC
  - Efficacy Overview
  - Overall Survival
  - Study E4599 Histologies
  - NCCN Guidelines
  - Duration
  - Patient Inclusion
  - Benefit-Risk Ratio
- Dosing and Duration
- NSCLC Resources
  - NSCLC Downloads
- Safety Information
- Prescribing Information